Today, the company advises that the meeting will be virtual-only due to concerns related to COVID-19 and potential risks to the health of meeting attendees. This possibility was signalled in the Notice of Meeting document.

“We regret to inform our shareholders that we will again be holding a virtual-only meeting this year,” said Scott St John, Board Chair. “We did not want our event to contribute to the potential spread of COVID-19 and flu when numbers have been stubbornly high through these winter months. An in-person option this year would also have been somewhat restrictive given the recommended mask and social distancing guidelines for indoor events in New Zealand. We feel this decision is in the best interest of our shareholders and appreciate their understanding.

“We strongly prefer hybrid meetings, and we very much value the in-person interactions we have had in past events. We have every intention of returning to this format in the future,” said Mr St John.

Instructions for Annual Shareholders’ Meeting virtual attendance

To participate at the meeting online, go to www.virtualmeeting.co.nz/FPH22. You will require your shareholder number, found on your proxy form, for verification purposes.

Shareholders participating in the meeting online will be able to vote and ask questions. Members of the Board will answer as many of the questions as possible during the meeting. Instructions for online participation and voting can be found in the company’s Notice of Meeting located at www.fphcare.com/asm. Shareholders may also call the Link Market Services helpline on 0800 200 220 should they require assistance.

Shareholders wishing to join the meeting by telephone can dial 0800 449 170 in New Zealand and 1800 896 574 in Australia. For those outside of New Zealand or Australia, dial +64 800 449 170.

 

About Fisher & Paykel Healthcare

Fisher & Paykel Fisher Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in more than 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.

 

Ends

 

Contact

Media: Karen Knott GM Corporate Communications karen.knott@fphcare.co.nz +64 (0) 21 713 911   Investors: Hayden Brown Investor Relations Manager hayden.brown@fphcare.co.nz +64 (0) 27 807 8073

Authorised by Fisher & Paykel Healthcare Corporation Limited’s Board Chair.